|
|
|
|
|||||
|
|
|
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report second quarter 2025 financial results on August 5, 2025, before the open of the U.S. financial markets. The company does not intend to hold a conference call.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.
Investors and Media:
Elizabeth Hickin
[email protected]
[email protected]
Source: Tango Therapeutics, Inc.
| Jul-30 | |
| Jul-30 | |
| Jul-29 | |
| Jul-22 | |
| Jul-14 | |
| Jun-30 | |
| Jun-27 | |
| Jun-23 | |
| May-27 | |
| May-21 | |
| May-12 | |
| May-12 | |
| May-09 | |
| May-06 | |
| May-05 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite